The Alliance for Regenerative Medicine and MEP Dr. Stelios Kympouropoulos held an event on November 29 at the European Parliament to outline how the EU can reverse its declining competitiveness and ensure patient access to transformative cell and gene therapies.
On October 19th, ARM and ASGCT will hold a meeting with FDA on the topic of potency assays for cell and gene therapies. The meeting will take place from 9 AM to 4 PM and will be live streamed for public viewing.
ARM held its first state event in Columbus in May, showcasing Ohio’s leadership in creating a hub for the cell and gene therapy field. The event will included a panel discussion from 4:00pm – 5:00pm, followed by a reception from 5:00pm – 7:00pm.
136 E Broad St. Columbus, OH 43215
This one-day meeting provides institutional, strategic and venture investors with unique insight into financing opportunities for cell and gene therapy-based treatment and tools. With significant technological advances and a number of recently approved products, the sector is poised for ever-increasing investor and analyst interest.
One East 60th Street
New York, NY 10022
ARM’s Annual EU Advanced Therapies Investor Day is the only European financing event organized specifically for the sector – providing institutional, strategic and venture investors a unique opportunity to gain insight into the top advanced therapies companies.
30 Euston Square,
Kings Cross,
London NW1 2FB, UK
